AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read

Van Den Born Simon sold $1.1M of MRX

Van Den Born Simon (President) sold 15,271 shares of Marex Group Ltd (MRX) at an average of $70.87 ($70.77–$71.36, $1.08M total) across 2 trades on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Van Den Born Simon
Published Sep 16, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$MRX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale reduces insider ownership modestly; market may view it as neutral.

02

Market read

Primary disclosure of a $1M insider sale; modest relevance for traders monitoring insider activity.

03

What to watch

The 10b5‑1 plan pre‑arranged nature may indicate no new information about the company's fundamentals.

Relevance 5/10Novelty 4/10Timing: filing posted after market close on 2026-09-16

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Market effects

Sector

Minimal impact on the broader brokerage and commodities services sector.

Regional

Limited to UK‑listed Marex investors; no broader regional effect.

Global

Low global relevance; only affects MRX shareholders.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • Company
    Marex Group Ltd

    UK‑based brokerage and commodities services firm.

  • Individual
    Van Den Born Simon

    President of Marex Group Ltd.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MRX insider trading history →

Related articles

AUG 16
$MRXMedAI 8/10

Marex Q2 Results Hit Record as Adjusted Profit Before Tax Surges 56%

Marex Group (NASDAQ: MRX) reported record Q2 2026 results. Revenue rose 39% to $695.8 million and adjusted profit before tax increased 56% to $165.9 million. Profit after tax more than doubled to $155.3 million and basic EPS rose 103% to $2.09. For H1, revenue was $1,388.1 million (+43%) and adjusted PBT $318.6 million (+57%).

leaprate.com4 min
AUG 15
$MRXMedAI 8/10

Why Marex Group Stock Popped Today

Marex Group (NASDAQ: MRX) reported Q2 results with revenue up 39% year over year to about $696 million and adjusted net income up 61% to $124 million, or $1.64 per share, versus analyst estimates of $589 million revenue and $1.36 per share. All four segments rose, and the company cited active acquisitions, with six deals closed and two pending.

aol.com2 min
AUG 14
$MRXMed

Marex Group plc Ordinary Shares Q2 2026 Earnings Call Summary

Marex Group plc reported record Q2 2026 adjusted profit before tax of $166 million, up 56% year on year, though exchange volumes fell 17% sequentially. Adjusted PBT margin rose to 24%. Management expects growth at the upper end of a 10% to 20% target range, with BrightPoint closing late 2026/early 2027 and margin expansion continuing gradually.

yahoo.com6 min
AUG 14
$MRXMedAI 8/10

Marex reports $318m profit for first half

Marex reported record adjusted profit before tax of $318m for the first half, up 79% year on year, and record Q2 adjusted profit before tax of $165.9m. Q2 after-tax profit was $155.3m, including a $35.1m gain from selling Winterflood’s custody business. Marex cited redomiciliation to Bermuda and revenue growth across segments.

royalgazette.com4 min